These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11794424)

  • 1. Sexual dysfunction secondary to gemfibrozil.
    James CW; Wu TS; McNelis KC
    Pharmacotherapy; 2002 Jan; 22(1):123-5. PubMed ID: 11794424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemfibrozil effectively lowers protease inhibitor-associated hypertriglyceridemia in HIV-1-positive patients.
    Hewitt RG; Shelton MJ; Esch LD
    AIDS; 1999 May; 13(7):868-9. PubMed ID: 10357393
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia.
    Miller J; Brown D; Amin J; Kent-Hughes J; Law M; Kaldor J; Cooper DA; Carr A
    AIDS; 2002 Nov; 16(16):2195-200. PubMed ID: 12409741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential drug-drug interaction between interferon alfa-2b and gemfibrozil in a patient with malignant melanoma.
    Wong SF; Jakowatz JG; Taheri R
    Clin Ther; 2005 Dec; 27(12):1942-8. PubMed ID: 16507380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia.
    Mastroianni CM; d'Ettorre G; Forcina G; Lichtner M; Corpolongo A; Coletta S; Vullo V
    AIDS; 2001 Apr; 15(6):820-1. PubMed ID: 11371708
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia.
    Tolentino MC; Ferenczi A; Ronen L; Poretsky L
    Endocr Pract; 2002; 8(3):208-12. PubMed ID: 12113634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities.
    Henry K; Melroe H; Huebesch J; Hermundson J; Simpson J
    Lancet; 1998 Sep; 352(9133):1031-2. PubMed ID: 9759748
    [No Abstract]   [Full Text] [Related]  

  • 8. Gemfibrozil treatment of hypertriglyceridemia: improvement on fibrinolysis without change of insulin resistance.
    Jeng JR; Jeng CY; Sheu WH; Lee MM; Huang SH; Shieh SM
    Am Heart J; 1997 Sep; 134(3):565-71. PubMed ID: 9327717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of protease inhibitor-associated hyperlipidemia.
    Penzak SR; Chuck SK
    Am J Cardiovasc Drugs; 2002; 2(2):91-106. PubMed ID: 14727985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in high density lipoprotein cholesterol (HDL-C) levels following gemfibrozil therapy.
    Lacko AG; Kudchodkar BJ; Loney WW; Clearfield MB; Weis S
    Clin Chem Lab Med; 1998 Jun; 36(6):389-92. PubMed ID: 9711427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Andrographis paniculata Extract on Triglyceride Levels of the Patients with Hypertriglyceridemia: A Randomized Controlled Trial.
    Phunikhom K; Khampitak K; Aromdee C; Arkaravichien T; Sattayasai J
    J Med Assoc Thai; 2015 Jul; 98 Suppl 6():S41-7. PubMed ID: 26434249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
    Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
    Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of fibrates in the management of hypertriglyceridemia.
    Rader DJ; Haffner SM
    Am J Cardiol; 1999 May; 83(9B):30F-35F. PubMed ID: 10357573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic pitfalls during therapy for extreme hypertriglyceridaemia.
    Orth M; Luley C
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):101-3. PubMed ID: 9056751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients.
    Mussoni L; Mannucci L; Sirtori C; Pazzucconi F; Bonfardeci G; Cimminiello C; Notarbartolo A; Scafidi V; Bittolo Bon G; Alessandrini P; Nenci G; Parise P; Colombo L; Piliego T; Tremoli E
    Atherosclerosis; 2000 Feb; 148(2):397-406. PubMed ID: 10657576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis associated with simvastatin-gemfibrozil therapy.
    Tal A; Rajeshawari M; Isley W
    South Med J; 1997 May; 90(5):546-7. PubMed ID: 9160078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hypoglycaemic episodes in a patient with Type 2 diabetes under fibrate therapy.
    Klein J; Ott V; Schütt M; Klein HH
    J Diabetes Complications; 2002; 16(3):246-8. PubMed ID: 12015195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Chan NN; Chow FC
    Lancet; 2001 Nov; 358(9295):1811; author reply 1811-2. PubMed ID: 11734263
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities.
    Thomas JC; Lopes-Virella MF; Del Bene VE; Cerveny JD; Taylor KB; McWhorter LS; Bultemeier NC
    Pharmacotherapy; 2000 Jun; 20(6):727-34. PubMed ID: 10853629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Serum Triglyceride Level and Gemfibrozil Consumption With Periodontal Status.
    Sayar F; Akhondi N; Fallah S; Moalemnia AA; Cheraghi A
    J Periodontol; 2017 May; 88(5):457-463. PubMed ID: 27958766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.